atazanavir sulfate has been researched along with parthenolide in 1 studies
Studies (atazanavir sulfate) | Trials (atazanavir sulfate) | Recent Studies (post-2010) (atazanavir sulfate) | Studies (parthenolide) | Trials (parthenolide) | Recent Studies (post-2010) (parthenolide) |
---|---|---|---|---|---|
1,102 | 246 | 590 | 612 | 5 | 323 |
Protein | Taxonomy | atazanavir sulfate (IC50) | parthenolide (IC50) |
---|---|---|---|
Nitric oxide synthase, inducible | Mus musculus (house mouse) | 4.525 | |
Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Antoine, B; Capeau, J; Chapron, C; Kadiri, S; Leroyer, S; Quette, J; Vatier, C | 1 |
1 other study(ies) available for atazanavir sulfate and parthenolide
Article | Year |
---|---|
Glyceroneogenesis is inhibited through HIV protease inhibitor-induced inflammation in human subcutaneous but not visceral adipose tissue.
Topics: Adult; Atazanavir Sulfate; Carrier Proteins; Female; Gene Expression; HIV Protease Inhibitors; Humans; Inflammation; Interleukin-6; Intra-Abdominal Fat; Lopinavir; Male; Nelfinavir; Oligopeptides; Perilipin-1; Phosphoenolpyruvate Carboxykinase (GTP); Phosphoproteins; Pyridines; Pyrimidinones; Ritonavir; Sesquiterpenes; Subcutaneous Fat; Triglycerides; Tumor Necrosis Factor-alpha | 2011 |